Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension

S. Oparil, I. Kobrin, D. R. Abernethy, B. S. Levine, M. C. Reif, A. M. Shepherd

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint Dive into the research topics of 'Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences